Cargando…
Infectious complications following Venetoclax-Proteasome Inhibitor based regimens in relapsed myeloma: a single center retrospective analysis
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7119194/ http://dx.doi.org/10.1016/j.clml.2019.09.206 |
| _version_ | 1783514726640123904 |
|---|---|
| author | Bernabei, Luca Sauter, Christopher Waxman, Adam Cohen, Adam Garfall, Alfred Vogl, Dan T. Erb, Colleen Mangan, Patricia Sanchez, Mary Stadtmauer, Edward |
| author_facet | Bernabei, Luca Sauter, Christopher Waxman, Adam Cohen, Adam Garfall, Alfred Vogl, Dan T. Erb, Colleen Mangan, Patricia Sanchez, Mary Stadtmauer, Edward |
| author_sort | Bernabei, Luca |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7119194 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71191942020-04-08 Infectious complications following Venetoclax-Proteasome Inhibitor based regimens in relapsed myeloma: a single center retrospective analysis Bernabei, Luca Sauter, Christopher Waxman, Adam Cohen, Adam Garfall, Alfred Vogl, Dan T. Erb, Colleen Mangan, Patricia Sanchez, Mary Stadtmauer, Edward Clin Lymphoma Myeloma Leuk Article Published by Elsevier Inc. 2019-10 2019-10-18 /pmc/articles/PMC7119194/ http://dx.doi.org/10.1016/j.clml.2019.09.206 Text en Copyright © 2019 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Bernabei, Luca Sauter, Christopher Waxman, Adam Cohen, Adam Garfall, Alfred Vogl, Dan T. Erb, Colleen Mangan, Patricia Sanchez, Mary Stadtmauer, Edward Infectious complications following Venetoclax-Proteasome Inhibitor based regimens in relapsed myeloma: a single center retrospective analysis |
| title | Infectious complications following Venetoclax-Proteasome Inhibitor based regimens in relapsed myeloma: a single center retrospective analysis |
| title_full | Infectious complications following Venetoclax-Proteasome Inhibitor based regimens in relapsed myeloma: a single center retrospective analysis |
| title_fullStr | Infectious complications following Venetoclax-Proteasome Inhibitor based regimens in relapsed myeloma: a single center retrospective analysis |
| title_full_unstemmed | Infectious complications following Venetoclax-Proteasome Inhibitor based regimens in relapsed myeloma: a single center retrospective analysis |
| title_short | Infectious complications following Venetoclax-Proteasome Inhibitor based regimens in relapsed myeloma: a single center retrospective analysis |
| title_sort | infectious complications following venetoclax-proteasome inhibitor based regimens in relapsed myeloma: a single center retrospective analysis |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7119194/ http://dx.doi.org/10.1016/j.clml.2019.09.206 |
| work_keys_str_mv | AT bernabeiluca infectiouscomplicationsfollowingvenetoclaxproteasomeinhibitorbasedregimensinrelapsedmyelomaasinglecenterretrospectiveanalysis AT sauterchristopher infectiouscomplicationsfollowingvenetoclaxproteasomeinhibitorbasedregimensinrelapsedmyelomaasinglecenterretrospectiveanalysis AT waxmanadam infectiouscomplicationsfollowingvenetoclaxproteasomeinhibitorbasedregimensinrelapsedmyelomaasinglecenterretrospectiveanalysis AT cohenadam infectiouscomplicationsfollowingvenetoclaxproteasomeinhibitorbasedregimensinrelapsedmyelomaasinglecenterretrospectiveanalysis AT garfallalfred infectiouscomplicationsfollowingvenetoclaxproteasomeinhibitorbasedregimensinrelapsedmyelomaasinglecenterretrospectiveanalysis AT vogldant infectiouscomplicationsfollowingvenetoclaxproteasomeinhibitorbasedregimensinrelapsedmyelomaasinglecenterretrospectiveanalysis AT erbcolleen infectiouscomplicationsfollowingvenetoclaxproteasomeinhibitorbasedregimensinrelapsedmyelomaasinglecenterretrospectiveanalysis AT manganpatricia infectiouscomplicationsfollowingvenetoclaxproteasomeinhibitorbasedregimensinrelapsedmyelomaasinglecenterretrospectiveanalysis AT sanchezmary infectiouscomplicationsfollowingvenetoclaxproteasomeinhibitorbasedregimensinrelapsedmyelomaasinglecenterretrospectiveanalysis AT stadtmaueredward infectiouscomplicationsfollowingvenetoclaxproteasomeinhibitorbasedregimensinrelapsedmyelomaasinglecenterretrospectiveanalysis |